| 1. |
王強, 李幼平, 張伯禮, 等. 指南臨床適用性評價的問題與需求. 中國循證醫學雜志, 2020, 20(3): 249-251.
|
| 2. |
Vogel JP, Dowswell T, Lewin S, et al. Developing and applying a 'living guidelines' approach to WHO recommendations on maternal and perinatal health. BMJ Glob Health, 2019, 4(4): e001683.
|
| 3. |
World Health Organization. Selected practice recommendations for contraceptive use (3rd edition). Geneva: World Health Organization, 2016.
|
| 4. |
Siu AL, Bibbins-Domingo K, et al. Screening for depression in adults: US preventive services task force recommendation statement. JAMA, 2016, 315(4): 380-387.
|
| 5. |
Wright L, Hill KM, Bernhardt J, et al. Stroke management: updated recommendations for treatment along the care continuum. Intern Med J, 2012, 42(5): 562-569.
|
| 6. |
Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews: 4. living guideline recommendations. J Clin Epidemiol, 2017, 91: 47-53.
|
| 7. |
World Health Organization. Therapeutics and COVID-19: living guideline. 2022.
|
| 8. |
World Health Organization. Drugs to prevent COVID-19: a WHO living guideline. 2022.
|
| 9. |
World Health Organization. Clinical management of COVID-19 patients: living guideline. 2022.
|
| 10. |
孫鑫, 李玲, 李舍予, 等. 促進高質量臨床實踐指南快速制訂與有效使用: MAGIC體系與中國行動. 中國循證醫學雜志, 2020, 20(1): 2-6.
|
| 11. |
MAGIC. MAGIC app. 2022.
|
| 12. |
張遷, 王琪, 后亮瑛, 等. 動態指南制訂方法及案例介紹. 中國循證醫學雜志, 2021, 21(4): 491-496.
|
| 13. |
Vogel JP, Tendal B, Giles M, et al. Clinical care of pregnant and postpartum women with COVID-19: living recommendations from the National COVID-19 Clinical Evidence Taskforce. Aust N Z J Obstet Gynaecol, 2020, 60(6): 840-851.
|
| 14. |
World Health Organization. WHO guidelines for malaria. Geneva: World Health Organization, 2022.
|
| 15. |
El Mikati IK, Khabsa J, Harb T, et al. A framework for the development of living practice guidelines in health care. Ann Intern Med, 2022, 175(8): 1154-1160.
|
| 16. |
Martínez García L, Sanabria AJ, García Alvarez E, et al. The validity of recommendations from clinical guidelines: a survival analysis. CMAJ, 2014, 186(16): 1211-1219.
|
| 17. |
鄭卿勇, 程露穎, 許建國, 等. 動態系統評價的研究現狀與進展. 中國藥物評價, 2021, 38(6): 471-478.
|
| 18. |
Dixon C, Dixon PE, Sultan S, et al. Guideline developers in the United States were inconsistent in applying criteria for appropriate grading of recommendations, assessment, development and evaluation use. J Clin Epidemiol, 2020, 124: 193-199.
|
| 19. |
曾力楠, 張伶俐. COVID-19證據現狀對快速建議指南制訂的啟示與思考. 協和醫學雜志, 2021, 12(4): 544-551.
|
| 20. |
林夏, 楊克虎, 陳耀龍, 等. 中國臨床實踐指南的現狀與思考. 中國循證醫學雜志, 2017, 17(5): 497-500.
|
| 21. |
靳英輝, 段冬雪, 曾憲濤, 等. 臨床實踐指南制定方法—指南的注冊與計劃書設計與撰寫. 中國循證心血管醫學雜志, 2018, 10(2): 129-132,137.
|
| 22. |
Elliott JH, Synnot A, Turner T, et al. Living systematic review: 1. introduction-the why, what, when, and how. J Clin Epidemiol, 2017, 91: 23-30.
|
| 23. |
Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-842.
|
| 24. |
Chen Y, Yang K, Maru?ic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.
|
| 25. |
楊楠, 趙巍, 潘旸, 等. 針對臨床實踐指南科學性、透明性和適用性的評級工具研發. 中華醫學雜志, 2022, 102(30): 2329-2337.
|
| 26. |
賴鴻皓, 孫銘謠, 黃嘉杰, 等. 中西醫結合臨床實踐指南實施框架構建的思考. 協和醫學雜志, 2023, 14(1): 31-38.
|